Giddings J C, Hall P, Basterfield P, Kennedy D A, George A J, Hall R, Lamont J, Stirling Y
Med Lab Sci. 1989 Jan;46(1):39-44.
Results of prothrombin time tests for the control of oral anticoagulant therapy, when using automated blood coagulation instruments (coagulometers), may not be the same as those obtained when using manual methods, and variation in coagulometer performance may affect clinical interpretation of data. The haematology advisory committee of the Institute of Medical Laboratory Sciences has recommended that coagulometers should be used for determination of prothrombin times only if it can be demonstrated that the results are valid when compared with those of a standardised manual method. A protocol for the evaluation of coagulometers, and details of the procedures, are given in this report, the main emphasis of which is on the assessment of instruments for determination of the International Normalised Ratio. Guidelines are also provided for the general use of machines of this type and for the assessment of safety. The principles of the protocol are applicable to other automated tests of blood coagulation.
在使用自动血液凝固仪(凝血计)控制口服抗凝治疗时,凝血酶原时间测试的结果可能与使用手工方法时获得的结果不同,并且凝血计性能的变化可能会影响数据的临床解读。医学检验科学研究所血液学咨询委员会建议,只有在能够证明与标准化手工方法相比结果有效的情况下,才应使用凝血计来测定凝血酶原时间。本报告给出了凝血计评估方案及程序细节,其主要重点是评估用于测定国际标准化比值的仪器。还提供了此类仪器的一般使用指南及安全性评估指南。该方案的原则适用于其他血液凝固自动检测。